Literature DB >> 18819815

Antitumor studies. Part 5: Synthesis, antitumor activity, and molecular docking study of 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins.

Ajaya R Shrestha1, Hamed I Ali, Noriyuki Ashida, Tomohisa Nagamatsu.   

Abstract

Various novel 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins derivatives have been synthesized by direct coupling of 5-deazaflavins and N-alkyl or aryl amines. The antitumor activities against human tumor cell lines CCRF-HSB-2 and KB cells have been investigated in vitro and many compounds showed promising potential antitumor activities with less cytotoxicities. AutoDock molecular docking into PTK (PDB code: 1t46) has been done for lead optimization of these compounds as potential PTK inhibitors. Some of the synthesized 5-(monosubstituted amino)-2-deoxo-2-phenyl-5-deazaflavins at the 5-position exhibited reasonable binding affinities into PTK with the hydrogen bond through their C(5)-NH moiety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819815     DOI: 10.1016/j.bmc.2008.09.022

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors.

Authors:  Hamed Ismail Ali; Tomofumi Nagamatsu; Eiichi Akaho
Journal:  Bioinformation       Date:  2011-02-07

2.  5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2.

Authors:  Michael P Dickens; Patricia Roxburgh; Andreas Hock; Mokdad Mezna; Barrie Kellam; Karen H Vousden; Peter M Fischer
Journal:  Bioorg Med Chem       Date:  2013-09-25       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.